Cargando…
Novel cis-trans interactions are involved in post-transcriptional regulation of cyclin-dependent kinase inhibitor p21(WAF1/CIP1 )mRNA
BACKGROUND: A variety of pathways target CDKI p21(WAF1/CIP1 )expression at transcriptional, post-transcriptional as well as translational levels. We previously found that cell growth suppressing retinoid CD437 enhanced expression of p21(WAF1/CIP1 )and DNA damage inducible GADD45 proteins in part by...
Autores principales: | Zhang, Liyue, Wali, Anil, Fontana, Joseph A, Dawson, Marcia I, Rishi, Arun K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927583/ https://www.ncbi.nlm.nih.gov/pubmed/20704727 http://dx.doi.org/10.1186/1750-2187-5-12 |
Ejemplares similares
-
Reciprocal role of cyclins and cyclin kinase inhibitor p21(WAF1/CIP1 )on lymphocyte proliferation, allo-immune activation and inflammation
por: Khanna, Ashwani K
Publicado: (2005) -
The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma
por: Sorteberg, Agnes Luise, et al.
Publicado: (2022) -
Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21(waf1/cip1 )among human bronchogenic carcinomas
por: Harr, Michael W, et al.
Publicado: (2005) -
Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
por: Shi, Y., et al.
Publicado: (1996) -
The Role of the Cyclin Dependent Kinase Inhibitor p21(cip1/waf1) in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics
por: Al Bitar, Samar, et al.
Publicado: (2019)